NYKODE TOLERANCE NORWAY AS
Pioneering immunotherapy platform unlocking future medicine for serious diseases.
Overview
- Unknown
- Employees
- Unknown
- Revenue
- 2024
- Founded
Key Decision Makers
Michael Engsig
Chief Executive Officer
Harald Gurvin
Chief Financial Officer
Louise Stubbe
Chief Legal Officer
Agnete B. Fredriksen
Chief Scientific Officer & Business Development
Description
Nykode Therapeutics ASA is a biotechnology company dedicated to advancing human health through innovative medical science. The core of their operation is the proprietary Vaccibody molecule, which forms an unrivalled modular technology platform. This platform is designed to induce fast, strong, and l...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Unknown
- Legal Form
- Aksjeselskap
- VAT Number
- Unknown
Decision Makers
4 contacts in FunnelfeedrMichael Engsig
Chief Executive Officer
Harald Gurvin
Chief Financial Officer
Louise Stubbe
Chief Legal Officer
Agnete B. Fredriksen
Chief Scientific Officer & Business Development
Similar Companies
20 similar companies in Funnelfeedr
INCYTE BIOSCIENCES NORWAY AS
Global biopharmaceutical company developing innovative medicines for patients.
CELLMOVER AS
7 employeesPre-clinical immunotherapy company optimizing immune cell targeting for cancer.
ROCHE DIAGNOSTICS NORGE AS
98 employeesGlobal leader in pharmaceuticals and diagnostics driving personalized medicine.
ROCHE NORGE AS
47 employeesGlobal leader pioneering personalized medicine through pharmaceuticals and diagnostics.
Oncotech Nordic AB
0 employeesDeveloping AI diagnostics and immunotherapy to conquer global cancer.
Browse More
NYKODE TOLERANCE NORWAY AS Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo